Key terms
About REGN
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, George Damis Yancopoulos, and Eric M. Shooter on January 8, 1988, and is headquartered in Tarrytown, NY.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest REGN news
Yesterday
9:00am ET
Wall Street Analysts Are Bullish on Top Healthcare Picks
Yesterday
6:55am ET
Cantor Fitzgerald Reaffirms Their Hold Rating on Regeneron (REGN)
Apr 12
8:33am ET
Analysts Are Bullish on These Healthcare Stocks: BioMarin Pharmaceutical (BMRN), Regeneron (REGN)
Apr 12
7:00am ET
Regeneron price target raised to $720 from $710 at BofA
Apr 12
5:20am ET
Analysts Offer Insights on Healthcare Companies: Teladoc (TDOC), Instil Bio (TIL) and Regeneron (REGN)
Apr 11
11:58am ET
RBC sees buying opportunity following Regeneron’s ‘overdone DOJ downside’
Apr 10
4:26pm ET
DOJ files false claims act complaint against Regeneron over drug pricing
Apr 09
6:45am ET
Regeneron (REGN) Receives a Buy from RBC Capital
Apr 09
5:50am ET
Analysts Offer Insights on Healthcare Companies: Regeneron (REGN), Veeva Systems (VEEV) and Ultragenyx Pharmaceutical (RARE)
Apr 07
4:49pm ET
Regeneron presents pivotal data from Phase 1/2 LINKER-MM1 trial of linvoseltamab
Apr 03
7:03pm ET
LLY, REGN, BHVN: Which Biotech Stock Offers the Most Upside?
Mar 26
8:45am ET
Truist Financial Remains a Buy on Regeneron (REGN)
Mar 26
4:51am ET
Analysts Offer Insights on Healthcare Companies: United Therapeutics (UTHR), Regeneron (REGN) and Intuitive Surgical (ISRG)
Mar 25
12:40pm ET
Analysts Offer Insights on Healthcare Companies: Regeneron (REGN) and Alphatec Holdings (ATEC)
Mar 25
12:31pm ET
Analysts Offer Insights on Healthcare Companies: Alphatec Holdings (ATEC) and Regeneron (REGN)
Mar 25
7:02am ET
Regeneron receives CRL from FDA on odronextamab BLA
Mar 19
1:36am ET
Buy Rating Affirmed for Regeneron on Eylea HD Success and Innovative Obesity Program
Mar 13
7:09am ET
Regeneron price target raised to $1,115 from $1,104 at Morgan Stanley
Mar 13
5:01am ET
Analysts’ Top Healthcare Picks: Cooper Co (COO), Regeneron (REGN)
Mar 12
9:51am ET
Oracle, Dollar General upgraded: Wall Street’s top analyst calls
Mar 11
4:11pm ET
Regeneron initiated with an Outperform at Bernstein
Mar 11
7:37am ET
Regeneron says FDA has extended approval of Praluent
Mar 08
7:30am ET
Analysts Are Bullish on Top Healthcare Stocks: Amgen (AMGN), Regeneron (REGN)
Mar 08
7:06am ET
Regeneron published one-year results from PULSAR, PHOTON, met primary endpoint
Mar 05
7:28am ET
2seventy bio: Close of asset sale to Regeneron seen in 1H24
Feb 27
8:34am ET
Regeneron price target raised to $1,184 from $1,096 at RBC Capital
Feb 27
7:51am ET
Analysts Are Bullish on Top Healthcare Stocks: ANI Pharmaceuticals (ANIP), Boston Scientific (BSX)
Feb 27
7:47am ET
Truist Financial Gives a Buy Rating to Regeneron (REGN)
Feb 27
12:30am ET
Analysts Offer Insights on Healthcare Companies: Korro Bio (KRRO), Relay Therapeutics (RLAY) and Regeneron (REGN)
Feb 23
7:25am ET
Buy Rating Affirmed: Regeneron’s Strategic Growth in Obesity Metabolic Space
Feb 23
5:16am ET
Regeneron, Sanofi announce FDA acceptance for priority review of Dupixent sBLA
Apr 16
10:05pm ET
IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces it is Investigating Claims Against Regeneron Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm
Apr 15
7:00am ET
ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Regeneron Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm
Apr 15
6:00am ET
IMPORTANT SHAREHOLDER ALERT: The Schall Law Firm Announces it is Investigating Claims Against Regeneron Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm
Apr 13
6:00am ET
INVESTOR ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Regeneron Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm
Apr 12
4:30am ET
IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces it is Investigating Claims Against Regeneron Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm
Mar 14
10:40am ET
Kuehn Law Encourages Investors of Regeneron Pharmaceuticals, Inc. to Contact Law Firm
REGN Financials
Key terms
Ad Feedback
REGN Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
REGN Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range